Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 0 | Agonist activity at TSHR expressed in HEK293 EM cells measured by intracellular cAMP accumulation | ChEMBL. | 16789744 |
EC50 (functional) | 0 | Agonist activity at LHCGR expressed in HEK293 EM cells measured by intracellular cAMP accumulation | ChEMBL. | 16789744 |
Efficacy (functional) | = 1.5 % | Agonist activity at TSHR expressed in HEK293 EM cells measured by intracellular cAMP accumulation relative to TSH | ChEMBL. | 16789744 |
Efficacy (functional) | = 1.5 % | Agonist activity at TSHR expressed in HEK293 EM cells measured by intracellular cAMP accumulation relative to TSH | ChEMBL. | 16789744 |
Efficacy (functional) | = 4.2 % | Agonist activity at LHCGR expressed in HEK293 EM cells measured by intracellular cAMP accumulation relative to LH | ChEMBL. | 16789744 |
Efficacy (functional) | = 4.2 % | Agonist activity at LHCGR expressed in HEK293 EM cells measured by intracellular cAMP accumulation relative to LH | ChEMBL. | 16789744 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.